Paul Tudor Jones Trans Medics Group, Inc. Transaction History

Tudor Investment Corp Et Al

$200 Billion
Q3 2025

A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 4,138 shares of TMDX stock, worth $475,911. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,138

Previous 123,716 96.66%

Holding current value

$475,911

Previous $16.6 Million 97.2%

% of portfolio

0.0%

Previous 0.04%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$103.61 - $132.04 $12.4 Million - $15.8 Million	-119,578 Reduced 96.66%	4,138 $464,000
Q2 2025 Aug 14, 2025	BUY	$67.67 - $143.04 $1.28 Million - $2.7 Million	18,890 Added 18.02%	123,716 $16.6 Million
Q1 2025 May 15, 2025	BUY	$56.73 - $79.42 $5.95 Million - $8.33 Million	104,826 New	104,826 $7.05 Million
Q2 2024 Aug 14, 2024	BUY	$72.62 - $150.62 $330,566 - $685,622	4,552 Added 67.43%	11,303 $1.7 Million
Q1 2024 May 15, 2024	SELL	$70.86 - $89.93 $5.68 Million - $7.21 Million	-80,190 Reduced 92.23%	6,751 $499,000
Q4 2023 Feb 14, 2024	BUY	$36.74 - $81.08 $1.77 Million - $3.9 Million	48,110 Added 123.9%	86,941 $6.86 Million
Q3 2023 Nov 15, 2023	BUY	$53.47 - $96.07 $2.08 Million - $3.73 Million	38,831 New	38,831 $2.13 Million
Q1 2023 May 15, 2023	SELL	$53.63 - $82.33 $1.91 Million - $2.93 Million	-35,628 Reduced 46.75%	40,582 $3.07 Million
Q4 2022 Feb 14, 2023	SELL	$39.08 - $64.29 $265,587 - $436,914	-6,796 Reduced 8.19%	76,210 $4.7 Million
Q3 2022 Nov 14, 2022	BUY	$31.56 - $55.75 $2.35 Million - $4.16 Million	74,584 Added 885.59%	83,006 $3.47 Million
Q2 2022 Aug 15, 2022	BUY	$20.56 - $32.15 $173,156 - $270,767	8,422 New	8,422 $265,000

Others Institutions Holding TMDX

# of Institutions

435

Shares Held

30.1M

Call Options Held

1.07M

Put Options Held

890K

View Full List

About TransMedics Group, Inc.

Ticker TMDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 31,831,400
Market Cap $3.66B
Description
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...

More about TMDX

Track Paul Tudor Jones's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.

Account